Allogene Therapeutics, Inc. (ALLO)
1.42
-0.03
(-2.07%)
USD |
NASDAQ |
Dec 09, 16:00
1.42
0.00 (0.00%)
After-Hours: 20:00
Allogene Therapeutics Total Liabilities (Quarterly): 124.44M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Akero Therapeutics, Inc. | 47.94M |
| ANI Pharmaceuticals, Inc. | 902.34M |
| AIM ImmunoTech, Inc. | 11.57M |
| Protalix Biotherapeutics, Inc. | 29.36M |
| Armata Pharmaceuticals, Inc. | 185.10M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 439.77M |
| Shareholders Equity (Quarterly) | 315.33M |
| Debt to Equity Ratio | 0.27 |
| Current Ratio | 8.190 |
| Net Debt Paydown Yield | 0.66% |